Sundaram Multi Pap quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Q1 FY26	Change
Revenue	49.6	40.7	+22.0%
EBITDA	1.2	1.1	+2.7%
EBITDA margin	2.3%	2.8%	−0.4 pts
Profit before tax	0.3	−0.4	—
Net profit	0.3	−0.4	—
EPS	₹0.01	−₹0.01	—

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Q2 FY24Sep 2023	Earlier quartersAlpha Plus

Expenses
	49.6	44.3	26.1	26.0	40.7	39.6	21.4	24.0	42.4	40.5	21.9	22.3	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	0.1	1.2	0.9	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.2
	49.7	45.5	26.9	26.0	40.7	41.6	21.4	24.0	42.4	40.6	21.9	22.5
	35.1	19.6	21.2	17.0	26.0	24.4	21.2	18.2	20.9	28.7	21.1	21.0
	0.6	1.0	0.2	0.3	0.3	0.7	0.5	0.6	0.4	0.4	0.2	0.3
	0.0	13.2	−7.2	−1.4	4.0	7.2	−7.0	−2.1	8.4	2.7	−5.1	−3.5
	4.9	4.7	5.1	4.1	4.2	4.2	4.1	3.1	3.0	3.0	3.3	2.7
	0.3	0.5	0.5	−0.1	0.7	0.7	0.8	0.6	0.6	0.8	1.0	0.8
	0.7	0.5	1.0	1.0	1.0	1.1	1.1	1.1	1.1	1.1	1.1	1.0
	7.9	4.9	4.7	4.3	5.1	4.3	3.4	4.2	6.0	3.2	2.9	2.1
	49.5	44.5	25.5	25.2	41.3	42.6	24.1	25.7	40.4	39.8	24.5	24.3
	1.2	0.9	2.1	1.8	1.1	−1.2	−0.9	−0.0	3.7	2.6	−0.5	−0.2
	0.4	0.4	1.0	0.7	0.1	−2.2	−2.0	−1.1	2.7	1.5	−1.5	−1.3
Profit
	0.2	1.1	1.4	0.8	−0.5	−1.0	−2.8	−1.7	2.0	0.8	−2.5	−1.8
	0.1	0.1	0.2	0.0	0.1	0.1	0.1	−0.1	−1.8	−0.5	0.4	−0.5
	0.3	1.2	1.6	0.8	−0.4	−0.9	−2.7	−1.8	0.3	0.2	−2.1	−2.3
	0.3	1.2	1.6	0.8	−0.4	−0.9	−2.7	−1.8	0.3	0.2	−2.1	−2.3
	0.3	1.2	1.6	0.8	−0.4	−0.9	−2.7	−1.8	0.3	0.2	−2.1	−2.3
	−0.0	−0.0	−0.0	−0.0	−0.0	0.0	−0.0	−0.0	−0.0	0.0	−0.0	−0.0
	0.3	1.2	1.6	0.8	−0.5	−0.8	−2.7	−1.8	0.2	0.3	−2.1	−2.4
Per share
	₹0.01	₹0.02	₹0.03	₹0.02	−₹0.01	−₹0.02	−₹0.06	−₹0.04	₹0.01	₹0.01	−₹0.05	−₹0.05
	₹0.01	₹0.02	₹0.03	₹0.02	−₹0.01	−₹0.02	−₹0.06	−₹0.04	₹0.01	₹0.01	−₹0.05	−₹0.05
Other comprehensive income — detail
	−0.0	−0.0	−0.0	−0.0	−0.0	0.0	—	—	—	—	—	—
	0.0	0.0	0.0	0.0	0.0	−0.0	—	—	—	—	—	—
	—	—	—	—	—	—	—	—	0.0	—	—	—
Per share — as-filed variants
	₹0.01	₹0.02	₹0.03	₹0.02	−₹0.01	−₹0.02	−₹0.06	−₹0.04	₹0.01	₹0.01	−₹0.05	−₹0.05
	₹0.01	₹0.02	₹0.03	₹0.02	−₹0.01	−₹0.02	−₹0.06	−₹0.04	₹0.01	₹0.01	−₹0.05	−₹0.05
Regulatory disclosures — filed alongside, not part of the P&L
	—	1.5	—	1.5	—	1.5	—	—	—	—	—	—
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	13.9	10.5	11.9	10.1	10.4	7.3	6.7	7.3	12.7	8.8	5.7	4.5
	28.1%	23.7%	45.6%	39.0%	25.5%	18.4%	31.2%	30.2%	30.0%	21.7%	26.0%	20.4%
Adjusted (ex-exceptional items) — derived
	0.2	1.1	1.4	0.8	−0.5	−1.0	−2.8	−1.7	2.0	0.8	−2.5	−1.8
	0.1	0.1	0.2	0.0	0.1	0.1	0.1	−0.1	−1.8	−0.5	0.4	−0.5
	0.2	1.1	1.4	0.8	−0.5	−1.0	−2.8	−1.7	2.0	0.8	−2.5	−1.8
	₹0.01	₹0.02	₹0.03	₹0.02	−₹0.01	−₹0.02	−₹0.06	−₹0.04	₹0.08	₹0.03	−₹0.06	−₹0.04

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

SUNDARAM₹1.03

Sundaram Multi Pap Limited

· FMCG & Retail

Annual Quarterly₹ CrorePeersLINC KOKUYOCMLN FLAIRMcap ₹48.8 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q2 FY24 30/09/2023	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	22.3	21.9	40.5	42.4	24.0	21.4	39.6	40.7	26.0	26.1	44.3	49.6
Other Income	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.9	1.2	0.1
Total Income	22.5	21.9	40.6	42.4	24.0	21.4	41.6	40.7	26.0	26.9	45.5	49.7
Expenses
+ Cost of Materials Consumed	21.0	21.1	28.7	20.9	18.2	21.2	24.4	26.0	17.0	21.2	19.6	35.1
+ Purchases of Stock-in-Trade	0.3	0.2	0.4	0.4	0.6	0.5	0.7	0.3	0.3	0.2	1.0	0.6
+ Changes in Inventories	-3.5	-5.1	2.7	8.4	-2.1	-7.0	7.2	4.0	-1.4	-7.2	13.2	0.0
+ Employee Benefit Expense	2.7	3.3	3.0	3.0	3.1	4.1	4.2	4.2	4.1	5.1	4.7	4.9
+ Finance Costs	0.8	1.0	0.8	0.6	0.6	0.8	0.7	0.7	-0.1	0.5	0.5	0.3
+ Depreciation & Amortisation	1.0	1.1	1.1	1.1	1.1	1.1	1.1	1.0	1.0	1.0	0.5	0.7
+ Other Expenses	2.1	2.9	3.2	6.0	4.2	3.4	4.3	5.1	4.3	4.7	4.9	7.9
Total Expenses	24.3	24.5	39.8	40.4	25.7	24.1	42.6	41.3	25.2	25.5	44.5	49.5
EBITDA	-0.2	-0.5	2.6	3.7	-0.0	-0.9	-1.2	1.1	1.8	2.1	0.9	1.2
EBIT	-1.3	-1.5	1.5	2.7	-1.1	-2.0	-2.2	0.1	0.7	1.0	0.4	0.4
Profit
PBT before Exceptional Items	-1.8	-2.5	0.8	2.0	-1.7	-2.8	-1.0	-0.5	0.8	1.4	1.1	0.2
+ Exceptional Items	-0.5	0.4	-0.5	-1.8	-0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1
Pretax Income	-2.3	-2.1	0.2	0.3	-1.8	-2.7	-0.9	-0.4	0.8	1.6	1.2	0.3
Net Income	-2.3	-2.1	0.2	0.3	-1.8	-2.7	-0.9	-0.4	0.8	1.6	1.2	0.3
+ Net Income — Continuing Ops	-2.3	-2.1	0.2	0.3	-1.8	-2.7	-0.9	-0.4	0.8	1.6	1.2	0.3
+ Other Comprehensive Income	-0.0	-0.0	0.0	-0.0	-0.0	-0.0	0.0	-0.0	-0.0	-0.0	-0.0	-0.0
Total Comprehensive Income	-2.4	-2.1	0.3	0.2	-1.8	-2.7	-0.8	-0.5	0.8	1.6	1.2	0.3
Per Share
Basic EPS	-0.05	-0.05	0.01	0.01	-0.04	-0.06	-0.02	-0.01	0.02	0.03	0.02	0.01
Diluted EPS	-0.05	-0.05	0.01	0.01	-0.04	-0.06	-0.02	-0.01	0.02	0.03	0.02	0.01
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	0.0	-0.0	-0.0	-0.0	-0.0	-0.0
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	-0.0	0.0	0.0	0.0	0.0	0.0
+ Tax on Items NOT to be Reclassified — alt tag	—	—	—	0.0	—	—	—	—	—	—	—	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	-0.05	-0.05	0.01	0.01	-0.04	-0.06	-0.02	-0.01	0.02	0.03	0.02	0.01
Diluted EPS — Continuing Operations	-0.05	-0.05	0.01	0.01	-0.04	-0.06	-0.02	-0.01	0.02	0.03	0.02	0.01
Regulatory Disclosures — filed alongside, not part of the P&L
Related-party Transactions — During the Period	—	—	—	—	—	—	1.5	—	1.5	—	1.5	—
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	4.5	5.7	8.8	12.7	7.3	6.7	7.3	10.4	10.1	11.9	10.5	13.9
Gross Margin %	20.38	26.02	21.74	30.00	30.21	31.17	18.42	25.48	38.97	45.61	23.71	28.08
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	-1.8	-2.5	0.8	2.0	-1.7	-2.8	-1.0	-0.5	0.8	1.4	1.1	0.2
− Exceptional Items (reconciliation)	-0.5	0.4	-0.5	-1.8	-0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1
Net Income Adj (tax-effected)	-1.8	-2.5	0.8	2.0	-1.7	-2.8	-1.0	-0.5	0.8	1.4	1.1	0.2
EPS Adj	-0.04	-0.06	0.03	0.08	-0.04	-0.06	-0.02	-0.01	0.02	0.03	0.02	0.01
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00
Paid Up Equity Capital	47.4	47.4	47.4	47.4	47.4	47.4	47.4	47.4	47.4	47.4	47.4	47.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Sundaram Multi Pap quarterly results

Sundaram Multi Pap (NSE: SUNDARAM) has not yet announced the date of its Q2 FY27 results (July–September 2026); they are due by 14 November 2026 under SEBI's 45-day rule. Its latest results are for Q1 FY27 (April–June 2026). Standalone net profit was ₹32 lakh, against a loss of ₹44 lakh in Q1 FY26 and down 72.9% from ₹1.2 crore in Q4 FY26. Revenue from operations was ₹49.6 crore, up 22.0% year on year and up 11.8% from the previous quarter.

Q2 FY26 results (a year earlier): 13 November 2025
Q1 FY27 results (the latest): 13 August 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · standalone

Q2 FY27 results due by: 14 November 202645 days after the quarter (SEBI)
Q1 FY27 net profit: ₹32 lakhloss ₹44 lakh in Q1 FY26−72.9% vs Q4 FY26
Q1 FY27 revenue: ₹49.6 Cr+22.0% vs Q1 FY26+11.8% vs Q4 FY26
Q1 FY27 operating margin: 0.9%+0.6 pts vs Q1 FY26unchanged vs Q4 FY26
Q2 FY26 net profit (a year earlier): ₹83 lakhRevenue ₹26 Cr
Q1 FY27 EPS (basic): ₹0.01

Questions

When will Sundaram Multi Pap announce its Q2 FY27 results?

The date is not announced yet. Results for July–September 2026 are due by 14 November 2026 (45 days after the quarter, SEBI Regulation 33). Last year it reported Q2 FY26 on 13 November 2025.

What will Sundaram Multi Pap's Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when standalone net profit was ₹83 lakh and revenue from operations ₹26 crore. The latest quarter, Q1 FY27, had a net profit of ₹32 lakh and revenue of ₹49.6 crore.

What were Sundaram Multi Pap's Q1 FY27 results?

Standalone net profit was ₹32 lakh, against a loss of ₹44 lakh in Q1 FY26 and down 72.9% from ₹1.2 crore in Q4 FY26. Revenue from operations was ₹49.6 crore, up 22.0% year on year and up 11.8% from the previous quarter.

How has Sundaram Multi Pap's profit changed over the last four quarters?

Net profit by quarter: ₹83 lakh in Q2 FY26, ₹1.6 crore in Q3 FY26, ₹1.2 crore in Q4 FY26 and ₹32 lakh in Q1 FY27. That is ₹3.9 crore over the four quarters. Revenue from operations: ₹26 crore, ₹26.1 crore, ₹44.3 crore and ₹49.6 crore.

What was Sundaram Multi Pap's net profit in FY26?

Standalone net profit was ₹3.2 crore in FY26 (April 2025–March 2026), against a loss of ₹5.1 crore in FY25. It was a loss of ₹5.1 crore in FY24 and a profit of ₹2.6 crore in FY23: up 22.8% over three years, 7.1% a year on average.

What was Sundaram Multi Pap's revenue in FY26?

Revenue from operations was ₹137 crore in FY26 (April 2025–March 2026), up 7.6% from ₹127 crore in FY25. It was ₹127 crore in FY24 and ₹114 crore in FY23: up 19.9% over three years, 6.2% a year on average.

Where do these Sundaram Multi Pap figures come from?

From Sundaram Multi Pap's own standalone results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Standalone figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.